Avastin

Genentech Faces Threat From New Erbitux Data

1 Comment

Eyeing Coverage: Ontario Blinks Over Lucentis

2 Comments

Friend Or Foe? The FDA’s Controversial Cancer Doc

3 Comments

GAO To Investigate FDA Review Process

3 Comments

Congress: No Hearing On Lucentis Pricing

1 Comment

BCA’s Brenner: Why Avastin Changes FDA Standards

2 Comments

FDA Approves Avastin For Breast Cancer

17 Comments

Genentech’s Avastin Slows Spread Of Breast Cancer

2 Comments

Pharmalot… Pharmalittle… Good Morning

Make a comment

ImClone Stock Pops On Erbitux Results

Make a comment

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/